Membrane shell of an implantable dosage system
AssigneeBayer Aktiengesellschaft
InventorsAntti Keinänen, Jukka Koskinen, Pentti Järvelä
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsAntti Keinänen, Jukka Koskinen, Pentti Järvelä
Estimating the term…
The membrane shell of an implantable dosage system according to the invention is particularly suitable for subcutaneous applications to release an active agent with steady amounts during a longer period of time. The membrane shell (3) according to the invention comprises a first half (1) and a second half (2), which both halves comprise a continuous closure edge (8, 9), and are adapted to be connected to each other through a closable joint. The closure edges (8, 9) of the halves comprise at least one groove (10) and/or at least one protrusion (11) as continuous or discontinuous, and the membrane shell (3) is adapted to be closed so that at least one protrusion (11) and/or at least one groove (10) of the second half becomes opposed to at least one groove (10) and/or at least one protrusion (11) of the first half through a snap-fit joint.
A membrane shell (3) of an implantable dosage system, comprising a first half (1) and a second half (2), which both halves comprise an inner surface (5;
Dependencies are inferred from the claim text.